We advised the underwriters on the SEC-registered stock offering

Davis Polk advised the representatives of the several underwriters in connection with the follow-on offering of 5,175,000 shares of common stock of Natera, Inc. for total gross proceeds of approximately $584.8 million, which includes 675,000 shares from the full exercise of the underwriters’ option to purchase additional shares. The shares are listed on the Nasdaq Global Select Market under the symbol “NTRA.”

Based in San Carlos, California, Natera is a diagnostics company with proprietary molecular and bioinformatics technology that it is applying to change the management of disease worldwide.

The Davis Polk corporate team included partner Alan F. Denenberg, counsel Jeffrey Gould and associates Sarah Masako Kirk and Lawrence Edward Traylor Jr. Partner Frank J. Azzopardi and associates Hilary Smith and S. Dream Montgomery provided intellectual property advice. The tax team included partner Michael Farber and associate Shay Moyal. Members of the Davis Polk team are based in the Northern California and New York offices.

Copy link to share post